Vincenza Conteduca
- Cancer Research top 1%
- Cancer Genomics and Diagnostics 35
- Cancer, Lipids, and Metabolism 20
-
- Prostate Cancer Treatment and Research 98
- Prostate Cancer Diagnosis and Treatment 25
- Renal cell carcinoma treatment 15
- Hepatology top 2%
- Oncology top 2%
- Cancer Immunotherapy and Biomarkers 15
- PARP inhibition in cancer therapy 10
-
- Radiopharmaceutical Chemistry and Applications 37
- Co-authors
- Ugo De GiorgiSabino RussiGianfranco LaulettaDomenico SansonnoFranco DammaccoHimisha BeltranCristian LolliMichele Aieta
- Journals
- Journal of Clinical Investigation (3 papers)Nature Communications (1 paper)Journal of Clinical Oncology (18 papers)
- Partner nations
- ItalyUnited KingdomUnited States
In The Last Decade
Vincenza Conteduca
141 papers receiving 3.7k citations
Hit Papers
Peers
Comparison fields: 5 of 115
- Cancer Research 1.1k
- Pulmonary and Respiratory Medicine 2.1k
- Hepatology 440
- Oncology 1.2k
- Radiology, Nuclear Medicine and Imaging 576
Countries citing papers authored by Vincenza Conteduca
This map shows the geographic impact of Vincenza Conteduca's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vincenza Conteduca with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vincenza Conteduca more than expected).
Fields of papers citing papers by Vincenza Conteduca
This network shows the impact of papers produced by Vincenza Conteduca. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vincenza Conteduca. The network helps show where Vincenza Conteduca may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Vincenza Conteduca, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 5 | |
| 2 | 2024 | 1 | |
| 3 | 2024 | 4 | |
| 4 | 2024 | 1 | |
| 5 | 2024 | 1 | |
| 6 | 2024 | 5 | |
| 7 | 2023 | 1 | |
| 8 | 2023 | 7 | |
| 9 | 2023 | 8 | |
| 10 | 2023 | 5 | |
| 11 | 2023 | 4 | |
| 12 | 2021 | 22 | |
| 13 | 2021 | 50 | |
| 14 | 2021 | 7 | |
| 15 | 2021 | 22 | |
| 16 | 2021 | 20 | |
| 17 | 2020 | 27 | |
| 18 | 2020 | 64 | |
| 19 | 2018 | 13 | |
| 20 | 2017 | 7 |
About Vincenza Conteduca
Vincenza Conteduca is a scholar working on Cancer Research, Pulmonary and Respiratory Medicine and Oncology, having authored 151 papers that have together received 3.8k indexed citations. Recurring topics across this work include Prostate Cancer Treatment and Research (98 papers), Radiopharmaceutical Chemistry and Applications (37 papers), Cancer Genomics and Diagnostics (35 papers), Prostate Cancer Diagnosis and Treatment (25 papers), Cancer, Lipids, and Metabolism (20 papers), Renal cell carcinoma treatment (15 papers), Cancer Immunotherapy and Biomarkers (15 papers) and PARP inhibition in cancer therapy (10 papers). The work is most often cited by research in Cancer Research (1.1k citations), Pulmonary and Respiratory Medicine (2.1k citations) and Hepatology (440 citations). Vincenza Conteduca has collaborated with scholars based in Italy, United Kingdom and United States. Frequent co-authors include Ugo De Giorgi, Sabino Russi, Gianfranco Lauletta, Domenico Sansonno, Franco Dammacco, Himisha Beltran, Cristian Lolli, Michele Aieta, Salvatore Luca Burgio and Dino Amadori. Their work appears in journals such as Journal of Clinical Investigation, Nature Communications and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.